Barrington Research Downgrades Haemonetics (HAE) to Market Perform

April 28, 2015 9:38 AM

Barrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform with a price target of $44.00. The change follows ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found